JNJohn M. Neuhaus

John M. Neuhaus

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John M. Neuhaus has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis

    by Ian E. McCoy, Kathleen D. Liu, Edward D. Siew, Delphine S. Tuot, Anitha Vijayan, Y. Diana Kwong, Gonzalo Matzumura Umemoto, Bethany C. Birkelo, John Neuhaus, Hanjing Zhuo, et al.

    Key Points: Timed urine creatinine clearance was superior to urine output and eGFR for predicting ongoing dialysis requirement in AKI. Even patients with measured creatinine clearance of e.g ., creatinine clearance less than 10 ml/min). Methods: In this ancillary study of the Liberation from Acute Dialysis (LIBERATE-D) trial intervention arm, timed urine collections blinded to clinicians were performed per protocol, and dialysis was performed for prespecified indications. Logistic regressions computed predicted probabilities of requiring dialysis in the subsequent 7 days by level of measured creatinine clearance, urea clearance, the average of creatinine and urea clearances, urine output, and eGFR calculated from serum creatinine. The fraction of patients requiring dialysis in the subsequent week at various thresholds of creatinine clearance and urine output were also reported. Results: Among 147 timed urine collections from 85 patients with AKI-D, median (interquartile range) creatinine clearance was 7.1 (3.1–15.9) ml/min and median urine output was 930 (471–1786) ml/d. Creatinine clearance demonstrated significantly higher discrimination (area under the receiver operating characteristic curve 0.84) than urine output (area under the receiver operating characteristic curve 0.78). Dialysis was not required in the subsequent week for 81% (22 of 27) of urine collections with creatinine clearance 10–20 ml/min and 44% (19 out of 43) with creatinine clearance 5 to <10 ml/min. Conclusions: In a clinical trial with protocolized dialysis indications for hemodynamically stable patients with AKI-D, patients with lower levels of kidney function, such as creatinine clearance of 5–10 ml/min, were often able to discontinue dialysis.

  • Open Access

    Digital Cognitive Behavioral Therapy for Insomnia Versus Sleep Hygiene Education for Prevention of Perinatal Depression: Protocol for a Randomized Clinical Trial

    by Jennifer N Felder, Patricia J Moran, Bernadette McClelland, Richelle Mah, Candance Sorensen, Carolyn Ponting, Nasim C Sobhani, John Neuhaus, Andrew Krystal, Rachel Manber

    Background: Insomnia during pregnancy is a modifiable risk factor for depression. Research in nonpregnant populations and preliminary findings in a pregnant population suggest that targeting insomnia with digital cognitive behavioral therapy for insomnia (CBT-I) may prevent depression. Objective: This study aims to evaluate the efficacy of digital CBT-I for the prevention of depression through 12 months post partum compared to that of a credible, clinically relevant comparator intervention, sleep hygiene education (SHE). This project will also provide valuable information about how and for whom CBT-I prevents perinatal depression. Methods: The Perinatal Research for Improving Sleep and Mental Health study is a fully remote, 2-arm parallel-group randomized controlled trial designed to test the superiority of digital CBT-I versus SHE for the prevention of perinatal depression. We aimed to randomize a target sample of at least 443 pregnant participants with insomnia disorder to digital CBT-I or SHE at a 1:1 ratio. Participants randomized to digital CBT-I received SleepioRx (Big Health, Inc), which uses sleep consolidation, stimulus control, cognitive therapy, relaxation techniques, and SHE in 6 interactive modules (5‐15 min each). Participants randomized to SHE received information about sleep hygiene, the impact of sleep on performance, healthy sleep habits, lifestyle influences on sleep, and creating a sleep-friendly bedroom in 6 weekly digital handouts. Data are collected at baseline, 5 weeks after randomization, 10 weeks after randomization, 36 weeks’ gestation, and 3, 6, 9, and 12 months post partum. The primary outcome is depression incidence, measured using the Structured Clinical Interview for DSM-5 ( Diagnostic and Statistical Manual of Mental Disorders [Fifth Edition]) Disorders, Research Version. Other outcome measures include the Edinburgh Postnatal Depression Scale, Patient Health Questionnaire-9, Columbia Suicide Severity Rating Scale, Generalized Anxiety Disorder Scale, and a birth outcomes questionnaire. Mediator measures include the Insomnia Severity Index, Consensus Sleep Diary, Structured Clinical Interview for Sleep Disorders, Perseverative Thinking Questionnaire, Dysfunctional Beliefs about Sleep Scale, Pre-sleep Arousal Scale, and Difficulties in Emotion Regulation-Short Form. Results: Data collection began in November 2022 and is projected to end in December 2026. Conclusions: If study hypotheses are supported, then this project will provide a new, scalable approach for preventing perinatal depression.

  • Open Access

    Data from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

    by Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter Carroll, June M. Chan

    Background:Inflammatory and insulin pathways have been linked to prostate cancer; postdiagnostic behaviors activating these pathways may lead to poor outcomes. The empirical dietary inflammatory pattern (EDIP), empirical dietary index for hyperinsulinemia (EDIH), and empirical dietary index for insulin resistance (EDIR), and associated lifestyle indices (ELIH, ELIR) predict biomarkers of inflammation (EDIP: IL6, TNFaR2, CRP) and insulin secretion (EDIH/ELIH: c-peptide; EDIR/ELIR: TAG:HDL) from whole foods and behaviors.Methods:Associations of these indices with time to prostate cancer progression (primary, n = 2,056) and prostate cancer–specific mortality (PCSM; secondary, n = 2,447) were estimated among men diagnosed with nonmetastatic prostate cancer in the Cancer of the Prostate Strategic Urologic Research Endeavor cohort diet and lifestyle sub-study. Because the true (versus clinically documented) date of progression is unobserved, we used parametric (Weibull) survival models to accommodate interval-censoringand estimated adjusted HR and 95% confidence intervals (CI) for prostate cancer progression per 1-SD increase in index. Cox proportional hazards models were used to estimate PCSM associations.Results:During a median [interquartile range (IQR)] 6.4 years (IQR, 1.3–12.7), 192 progression and 73 PCSM events were observed. Inflammatory (EDIP: HR, 1.27; CI, 1.17–1.37), hyperinsulinemic (EDIH: HR, 1.24; CI, 1.05–1.46. ELIH: HR, 1.34; CI, 1.17–1.54), and insulin-resistant (EDIR: HR, 1.22; CI, 1.00–1.48. ELIR: HR, 1.36; CI, 1.12–1.64) indices were positively associated with risk of prostate cancer progression. There was no evidence of associations between the indices and PCSM.Conclusions:Both inflammatory and insulinemic dietary and lifestyle patterns are associated with risk of prostate cancer progression.Impact:For men with prostate cancer, consuming dietary patterns that limit chronic systemic inflammation and insulin hypersecretion may improve survivorship, especially when coupled with active lifestyle and healthy body weight.See related commentary by Kucuk, p. 1673

  • Open Access

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

    by Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter Carroll, June M. Chan

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

  • Open Access

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

    by Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter Carroll, June M. Chan

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

  • Open Access

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

    by Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter Carroll, June M. Chan

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

  • Open Access

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

    by Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter Carroll, June M. Chan

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

  • Open Access

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

    by Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter Carroll, June M. Chan

    Supplementary Table from Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality

  • Open Access

    Improved prediction and flagging of extreme random effects for non-Gaussian outcomes using weighted methods

    by John Neuhaus, Charles McCulloch, Ross Boylan

    Investigators often focus on predicting extreme random effects from mixed effects models fitted to longitudinal or clustered data, and on identifying or “flagging” outliers such as poorly performing hospitals or rapidly deteriorating patients. Our recent work with Gaussian outcomes showed that weighted prediction methods can substantially reduce mean square error of prediction for extremes and substantially increase correct flagging rates compared to previous methods, while controlling the incorrect flagging rates. This paper extends the weighted prediction methods to non-Gaussian outcomes such as binary and count data. Closed-form expressions for predicted random effects and probabilities of correct and incorrect flagging are not available for the usual non-Gaussian outcomes, and the computational challenges are substantial. Therefore, our results include the development of theory to support algorithms that tune predictors that we call “self-calibrated” (which control the incorrect flagging rate using very simple flagging rules) and innovative numerical methods to calculate weighted predictors as well as to evaluate their performance. Comprehensive numerical evaluations show that the novel weighted predictors for non-Gaussian outcomes have substantially lower mean square error of prediction at the extremes and considerably higher correct flagging rates than previously proposed methods, while controlling the incorrect flagging rates. We illustrate our new methods using data on emergency room readmissions for children with asthma.